跳至主要内容
临床试验/NCT05173090
NCT05173090Unknown不适用

Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

University of Liege0 个研究点目标入组 120 人开始时间: 2022年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
120
主要终点
Patient's pain

研究概览

简要总结

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Appendectomy or cholecystectomy surgery

排除标准

  • Allergy to local anesthetics
  • Intolerance to tramadol HCl
  • Patient with peritonitis
  • Pregnant women
  • Surgery without laparoscopy
  • Chronic pain before the operation

研究组 & 干预措施

Ropivacaïne 0,5%

Active Comparator

3 mg/kg of ropivacaine 0.5% sprayed into the abdominal cavity

干预措施: Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery (Drug)

NaCl 0,9%

Placebo Comparator

NaCl 0,9% sprayed into the abdominal cavity

干预措施: Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery (Drug)

结局指标

主要结局

Patient's pain

时间窗: During appendectomy and cholecystectomy surgery

The patient's satisfaction was assessed by visual analog scale, ranging from one (worse outcome )to four (better outcome

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benjamin Javillier, MD

Principal investigator

University of Liege

相似试验